Skip to main content
. 2021 Jul 14;40(23):5096–5114. doi: 10.1002/sim.9113

FIGURE 1.

SIM-9113-FIG-0001-b

Illustration of the proposed modeling process of the bivariate toxicity endpoint at the end of the dose‐escalation phase of the trial